|
US4194047A
(en)
|
1975-11-21 |
1980-03-18 |
Merck & Co., Inc. |
Substituted N-methylene derivatives of thienamycin
|
|
US4260543A
(en)
|
1978-07-03 |
1981-04-07 |
Merck & Co., Inc. |
Crystalline N-formimidoyl thienamycin
|
|
US4409214A
(en)
|
1979-11-19 |
1983-10-11 |
Fujisawa Pharmaceutical, Co., Ltd. |
7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
CA1283404C
(en)
|
1986-07-01 |
1991-04-23 |
Shigeru Sanai |
Cephalosporin compounds, processes for their preparation and antibacterial agents
|
|
ZA893284B
(en)
|
1988-05-04 |
1990-03-28 |
Igen Inc |
Peptide analogs and their use as haptens to elicit catalytic antibodies
|
|
US5888998A
(en)
|
1997-04-24 |
1999-03-30 |
Synphar Laboratories, Inc. |
2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
|
|
US6075014A
(en)
|
1997-06-13 |
2000-06-13 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
|
US6184363B1
(en)
|
1997-06-13 |
2001-02-06 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
|
WO2000035904A1
(en)
|
1998-12-16 |
2000-06-22 |
Northwestern University |
INHIBITORS OF β-LACTAMASES AND USES THEREFOR
|
|
WO2000035905A1
(en)
|
1998-12-16 |
2000-06-22 |
Northwestern University |
INHIBITORS OF β-LACTAMASES AND USES THEREFOR
|
|
HUP0202787A3
(en)
|
1999-09-25 |
2003-12-29 |
Smithkline Beecham Plc |
Piperazine derivatives as 5-ht1b antagonists, process for their preparation and pharmaceutical compositions containing them
|
|
AU762935B2
(en)
|
1999-10-28 |
2003-07-10 |
Merck & Co., Inc. |
Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
|
|
AU2001292732A1
(en)
|
2000-09-12 |
2002-03-26 |
Larry C. Blasczcak |
Beta-lactam analogs and uses therefor
|
|
WO2002022613A1
(en)
|
2000-09-14 |
2002-03-21 |
Pantherix Limited |
3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
|
|
WO2002054931A2
(en)
|
2001-01-10 |
2002-07-18 |
Bristol Myers Squibb Company P |
Alpha-aminoboronic acids prepared by novel synthetic methods
|
|
DE10118698A1
(de)
|
2001-04-17 |
2002-11-07 |
Jerini Ag |
Verfahren zur Immobilisierung und damit hergestellte Anordnungen von Verbindungen auf einer planaren Oberfläche
|
|
FR2835186B1
(fr)
|
2002-01-28 |
2006-10-20 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
|
|
JP2003229277A
(ja)
|
2002-02-04 |
2003-08-15 |
Matsushita Electric Ind Co Ltd |
発光素子材料およびそれを用いた発光素子並びに装置
|
|
AUPS065102A0
(en)
|
2002-02-20 |
2002-03-14 |
Unisearch Limited |
Fluorous acetalation
|
|
AU2003261974A1
(en)
|
2002-09-11 |
2004-04-30 |
Kureha Chemical Industry Company, Limited |
Amine compounds and use thereof
|
|
AU2003268752A1
(en)
|
2002-10-30 |
2004-05-25 |
Sumitomo Chemical Company, Limited |
High-molecular compounds and polymerer light emitting devices made by using the same
|
|
US7439253B2
(en)
|
2002-12-06 |
2008-10-21 |
Novexel |
Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
|
|
US7271186B1
(en)
|
2002-12-09 |
2007-09-18 |
Northwestern University |
Nanomolar β-lactamase inhibitors
|
|
JP2006511587A
(ja)
|
2002-12-20 |
2006-04-06 |
ミジェニックス コーポレイション |
アデニンヌクレオチドトランスロカーゼ（ａｎｔ）リガンドならびにそれに関連する組成物および方法
|
|
TW200418791A
(en)
|
2003-01-23 |
2004-10-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions for inhibiting proteasome
|
|
JP4233365B2
(ja)
|
2003-03-25 |
2009-03-04 |
三井化学株式会社 |
アザジオール錯体化合物、及び該化合物を用いる光記録媒体
|
|
WO2005033090A1
(ja)
|
2003-10-06 |
2005-04-14 |
Sumitomo Chemical Company, Limited |
芳香族化合物
|
|
EP1678180B1
(en)
|
2003-10-10 |
2007-08-08 |
Pfizer Products Incorporated |
Substituted 2h-[1,2,4]triazolo 4,3-a pyrazines as gsk-3 inhibitors
|
|
TW200600494A
(en)
|
2004-03-08 |
2006-01-01 |
Chugai Pharmaceutical Co Ltd |
Bisphenyl compounds useful as vitamin d3 receptor agonists
|
|
US20060019116A1
(en)
|
2004-07-22 |
2006-01-26 |
Eastman Kodak Company |
White electroluminescent device with anthracene derivative host
|
|
US20060178357A1
(en)
|
2005-02-10 |
2006-08-10 |
Buynak John D |
Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases
|
|
JP5038912B2
(ja)
|
2005-02-16 |
2012-10-03 |
アナコール ファーマシューティカルズ，インコーポレイテッド |
ホウ素含有小分子
|
|
CA2683975A1
(en)
|
2005-02-22 |
2006-08-31 |
Teva Pharmaceutical Industries Ltd. |
Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
|
|
WO2006101779A2
(en)
|
2005-03-15 |
2006-09-28 |
The University Of Chicago |
Non-aqueous electrolytes for lithium ion batteries
|
|
TW200734311A
(en)
|
2005-11-21 |
2007-09-16 |
Astrazeneca Ab |
New compounds
|
|
ATE529111T1
(de)
|
2005-12-07 |
2011-11-15 |
Basilea Pharmaceutica Ag |
Nützliche monobactam-antibiotika
|
|
NZ570257A
(en)
|
2006-02-16 |
2011-11-25 |
Anacor Pharmaceuticals Inc |
Boron-containing small molecules as anti-inflammatory agents
|
|
WO2008039420A2
(en)
|
2006-09-27 |
2008-04-03 |
Merck & Co., Inc. |
Novel inhibitors of beta-lactamase
|
|
KR101320718B1
(ko)
|
2007-03-23 |
2013-10-21 |
바실리어 파마슈티카 아게 |
세균 감염 치료용 조합 약제
|
|
GB0719366D0
(en)
|
2007-10-03 |
2007-11-14 |
Smithkline Beecham Corp |
Compounds
|
|
US20100120715A1
(en)
|
2007-11-13 |
2010-05-13 |
Burns Christopher J |
Beta-lactamase inhibitors
|
|
CN101983203A
(zh)
|
2007-11-13 |
2011-03-02 |
诺瓦提斯国际药物有限公司 |
β-内酰胺酶抑制剂
|
|
MY162532A
(en)
|
2008-01-18 |
2017-06-15 |
Merck Sharp & Dohme |
Beta-lactamase inhibitors
|
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
|
US20100256092A1
(en)
|
2008-05-12 |
2010-10-07 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
|
US20110124634A1
(en)
|
2008-05-13 |
2011-05-26 |
Poniard Pharmaceuticals, Inc. |
Bioactive compounds for treatment of cancer and neurodegenerative diseases
|
|
US20120046242A1
(en)
|
2008-12-24 |
2012-02-23 |
Massachusetts Institute Of Technology |
Molecular activators of the wnt/beta-catenin pathway
|
|
WO2010097675A1
(en)
|
2009-02-27 |
2010-09-02 |
Dhanuka Laboratories Ltd. |
An improved preparation process for cefpodoxime proxetil
|
|
US20100292185A1
(en)
|
2009-05-12 |
2010-11-18 |
Burns Christopher J |
Beta-lactamase inhibitors
|
|
US20120238576A1
(en)
|
2009-06-08 |
2012-09-20 |
California Capital Equity, Llc |
Triazine Derivatives and their Therapeutical Applications
|
|
KR20130031233A
(ko)
|
2009-07-28 |
2013-03-28 |
아나코르 파마슈티칼스 인코포레이티드 |
삼치환된 붕소 함유 분자
|
|
CA2828114A1
(en)
|
2010-02-26 |
2011-09-01 |
Gary Igor DMITRIENKO |
Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof
|
|
US20110288063A1
(en)
|
2010-05-19 |
2011-11-24 |
Naeja Pharmaceutical Inc. |
Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
|
|
PL3412676T3
(pl)
|
2010-08-10 |
2021-04-06 |
Melinta Therapeutics, Inc. |
Cykliczne pochodne estrowe kwasu boronowego, sposób otrzymywania oraz ich zastosowania terapeutyczne
|
|
WO2012067664A1
(en)
|
2010-11-18 |
2012-05-24 |
Glaxo Group Limited |
Compounds
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
EP2508506A1
(en)
*
|
2011-04-08 |
2012-10-10 |
LEK Pharmaceuticals d.d. |
Preparation of sitagliptin intermediates
|
|
WO2013033461A1
(en)
|
2011-08-31 |
2013-03-07 |
Rempex Pharmaceuticals, Inc. |
Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
WO2013053372A1
(en)
|
2011-10-13 |
2013-04-18 |
Therabor Pharmaceuticals |
Boronic acid inhibitors of beta-lactamases
|
|
WO2013056163A1
(en)
|
2011-10-14 |
2013-04-18 |
The Regents Of The University Of California |
Beta-lactamase inhibitors
|
|
US9688702B2
(en)
*
|
2011-12-22 |
2017-06-27 |
Ares Trading |
Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
|
|
US20150018311A1
(en)
*
|
2012-01-09 |
2015-01-15 |
University of Tromsø |
Therapeutic boron-containing compounds
|
|
EP2814483A2
(en)
|
2012-02-15 |
2014-12-24 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
|
US9156858B2
(en)
|
2012-05-23 |
2015-10-13 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US10561675B2
(en)
|
2012-06-06 |
2020-02-18 |
Rempex Pharmaceuticals, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
PL2928898T3
(pl)
|
2012-12-07 |
2021-10-25 |
VenatoRx Pharmaceuticals, Inc. |
Inhibitory beta-laktamaz
|
|
US9241947B2
(en)
|
2013-01-04 |
2016-01-26 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9101638B2
(en)
|
2013-01-04 |
2015-08-11 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
EP2941246A4
(en)
|
2013-01-04 |
2016-12-21 |
Rempex Pharmaceuticals Inc |
BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USES
|
|
ES2730013T3
(es)
|
2013-01-10 |
2019-11-07 |
Venatorx Pharmaceuticals Inc |
Inhibidores de betalactamasa
|
|
US9944658B2
(en)
|
2013-03-14 |
2018-04-17 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|